|
| Group A (n = 7) | Group B (n = 10) | P |
| Gender Maleª Femaleª |
0 7 (41%) |
5 (29%) 5 (29%) | 0.041 |
| Age b (average in years) | 44.3 ±13.8 | 45.4± 15.9 | 0.880 |
| Unknown sarcoidosisª | 5 (29%) | 8 (47%) | 0.559 |
| HTAª | 1 (6%) | 2 (12%) | 0.640 |
| Creatinine clearance < 30 ml/min on admissionª | 5 (29%) | 5 (29%) | 0.354 |
| Hypercalcemiaª mg/l | 0 | 3 (18%) | 0.176 |
| Multisystem damageª (≥3 organs) | 3 (18%) | 6 (35%) | 0.419 |
| Renal biopsy: (n = 15) Granulomaª Fibrosis > 25%ª |
3 (18%) 2 (12%) |
4 (24%) 7 (41%) |
0.595 0.035 |
| Corticosteroid therapy: (n = 15) Form of treatment: Injectable treatmentª Oral treatment aloneª |
4 (24%) 5 (29%) |
3 (18%) 3 (18%) | 0.268 |
| Average treatment time (months)b | 17 ± 7.7 | 13.83 ± 7.55 | 0.490 |